Light controllable siRNAs regulate gene suppression and phenotypes in cells
Quan N. Nguyen(Nanospectra Biosciences (United States)), Gary McMaster, May C. Morris(Centre National de la Recherche Scientifique), Rajesh V. Chavli(Nanospectra Biosciences (United States)), João T. Marques(Universidade Federal de Minas Gerais), F. Heitz(Centre National de la Recherche Scientifique), Weihai He(Nanospectra Biosciences (United States)), Larry Pastor, Gilles Divita(Université de Montpellier), Frank Witney, Peter G. Conrad(Nanospectra Biosciences (United States)), Aiguo Zhang(Henan University), Barbara Belisle(Nanospectra Biosciences (United States)), Die Wang(Monash Institute of Medical Research), Bryan Williams(The London College)
Cited by 73
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension
|Lirias|2003|2.6k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
The OxyS regulatory RNA represses rpoS translation and binds the Hfq (HF‐I) protein
|The EMBO Journal|1998|788